Philip Jones, Ph.D., vice president of Therapeutics Discovery and head of the Institute for Applied Cancer Science, designed a hydrocarbon-stapled peptide, SP9, to block Syt2, based on structures developed by the Stanford collaborators, including senior co-corresponding author Axel Brunger, Ph.D., professor of Molecular and Cellular Physiology
Expedited shipping options available across Canada for fast delivery to your doorstep
Start with your study goals, then match your dosage accordingly
Common reactions are mild local injection site irritation
Ipamorelin with CJC-1295 Combining ipamorelin and CJC 1295, a peptide that stimulates pituitary gland function, increases growth hormone release